{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:05:19Z","timestamp":1766023519088,"version":"3.48.0"},"reference-count":35,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/kmwi9314","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:43:10Z","timestamp":1746510190000},"page":"1777-1789","source":"Crossref","is-referenced-by-count":0,"title":["Effect of gamma knife stereotactic radiotherapy on the hematological system in patients with advanced lung cancer and its therapeutic effect"],"prefix":"10.62347","volume":"15","author":[{"given":"Chun-Guang","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Huang T, Ren K, Ding G, Yang L, Wen Y, Peng B, Wang G and Wang Z. miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K\/Akt pathway. Oncol Rep 2020; 43: 1906-1914.","DOI":"10.3892\/or.2020.7547"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.7150\/jca.40196","article-title":"Sex differences and adverse effects between chemotherapy and immunotherapy for non-small cell lung cancer","volume":"11","author":"Tsiouda","year":"2020","unstructured":"Tsiouda T, Sardeli C, Porpodis K, Pilikidou M, Apostolidis G, Kyrka K, Miziou A, Kyrka K, Tsingerlioti Z, Papadopoulou S, Heva A, Koulouris C, Giannakidis D, Boniou K, Kesisoglou I, Vagionas A, Kosmidis C, Sevva C, Papazisis G, Goganau AM, Sapalidis K, Tsakiridis K, Tryfon S, Platanas M, Baka S, Zaric B, Perin B, Petanidis S and Zarogoulidis P. Sex differences and adverse effects between chemotherapy and immunotherapy for non-small cell lung cancer. J Cancer 2020; 11: 3407-3415.","journal-title":"J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, Wang N, Han R, Liu S, Li H, Mu H, He Y, Xu Y, Fu Z, Zhou Y, Jiang J, Yang Y, Chen J, Wei K, Fan D, Wang J, Fu F, Zhao D, Song G, Chen J, Jiang C, Zhou X, Gu X, Jin F, Li Q, Li Y, Wu T, Yan C, Dong J, Hua Z, Baade P, Bray F, Jemal A, Yu XQ and He J. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health 2018; 6: e555-e567.","DOI":"10.1016\/S2214-109X(18)30127-X"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13014-021-01889-0","article-title":"Effect of abdominal compression on target movement and extension of the external boundary of peripheral lung tumors treated with stereotactic radiotherapy based on four-dimensional computed tomography","volume":"16","author":"Qi","year":"2021","unstructured":"Qi Y, Li J, Zhang Y, Shao Q, Liu X, Li F, Wang J, Li Z and Wang W. Effect of abdominal compression on target movement and extension of the external boundary of peripheral lung tumors treated with stereotactic radiotherapy based on four-dimensional computed tomography. Radiat Oncol 2021; 16: 173.","journal-title":"Radiat Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"881460","DOI":"10.3389\/fonc.2022.881460","article-title":"Clinical outcomes and prognostic analysis of 101 patients of central neurocytoma: a 10-year treatment experience at a single institution","volume":"12","author":"Xie","year":"2022","unstructured":"Xie Q, Xie B, Ou L, Wang M, Tang Z, He Y, Yang X, Hong J, Lyu Z and Wei R. Clinical outcomes and prognostic analysis of 101 patients of central neurocytoma: a 10-year treatment experience at a single institution. Front Oncol 2022; 12: 881460.","journal-title":"Front Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/1759-7714.14532","article-title":"Gamma knife radiosurgery for patients with brain metastases from non-small cell lung cancer: comparison of survival between <5 and ≥5 metastases","volume":"13","author":"Zhao","year":"2022","unstructured":"Zhao X, Ding S, Zhang M and Wang C. Gamma knife radiosurgery for patients with brain metastases from non-small cell lung cancer: comparison of survival between <5 and ≥5 metastases. Thorac Cancer 2022; 13: 2152-2157.","journal-title":"Thorac Cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S1470-2045(24)00320-6","article-title":"Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial","volume":"25","author":"Vera","year":"2024","unstructured":"Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G and Giraud P. Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial. Lancet Oncol 2024; 25: 1176-1187.","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4103\/ijc.IJC_666_19","article-title":"Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy","volume":"59","author":"Akcay","year":"2022","unstructured":"Akcay M, Etiz D, Celik O and Ozen A. Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy. Indian J Cancer 2022; 59: 178-186.","journal-title":"Indian J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jtho.2024.01.019","article-title":"The international association for the study of lung cancer staging project for lung cancer: proposals for the revision of the M descriptors in the forthcoming ninth edition of the TNM classification for lung cancer","volume":"19","author":"KM","year":"2024","unstructured":"Fong KM, Rosenthal A, Giroux DJ, Nishimura KK, Erasmus J, Lievens Y, Marino M, Marom EM, Putora PM, Singh N, Suárez F, Rami-Porta R, Detterbeck F, Eberhardt WEE and Asamura H; Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Members of the Advisory Boards, and Participating Institutions of the Lung Cancer Domain. The international association for the study of lung cancer staging project for lung cancer: proposals for the revision of the M descriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol 2024; 19: 786-802.","journal-title":"J Thorac Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fphar.2019.00408","article-title":"Systems biology analysis of the effect and mechanism of Qi-Jing-Sheng-Bai granule on leucopenia in mice","volume":"10","author":"Tian","year":"2019","unstructured":"Tian S, Huang P, Gu Y, Yang J, Wu R, Zhao J, Liu AJ and Zhang W. Systems biology analysis of the effect and mechanism of Qi-Jing-Sheng-Bai granule on leucopenia in mice. Front Pharmacol 2019; 10: 408.","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41416-021-01368-z","article-title":"A phase 1\/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer","volume":"124","author":"Kim","year":"2021","unstructured":"Kim DW, Tan E, Zhou JM, Schell MJ, Martinez M, Yu J, Carballido E, Mehta R, Strosberg J, Imanirad I and Kim RD. A phase 1\/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer. Br J Cancer 2021; 124: 1803-1808.","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1017\/S1041610221000430","article-title":"PROTECT: a novel psychotherapy for late-life depression in elder abuse victims","volume":"33","author":"Sirey","year":"2021","unstructured":"Sirey JA, Solomonov N, Guillod A, Zanotti P, Lee J, Soliman M and Alexopoulos GS. PROTECT: a novel psychotherapy for late-life depression in elder abuse victims. Int Psychogeriatr 2021; 33: 521-525.","journal-title":"Int Psychogeriatr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"986367","DOI":"10.3389\/fonc.2022.986367","article-title":"Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma","volume":"12","author":"Zhao","year":"2022","unstructured":"Zhao J, Li G, Zhao G, Wang W, Shen Z, Yang Y, Huang Y and Ye L. Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma. Front Oncol 2022; 12: 986367.","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12935-022-02758-w","article-title":"RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC","volume":"22","author":"Cong","year":"2022","unstructured":"Cong S, Di X, Li R, Cao Y, Jin X, Tian C, Zhao M and Wang K. RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC. Cancer Cell Int 2022; 22: 338.","journal-title":"Cancer Cell Int"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/cells11071220","article-title":"Comprehensive analysis of CDK1-associated ceRNA network revealing the key pathways LINC00460\/LINC00525-Hsa-Mir-338-FAM111\/ZWINT as prognostic biomarkers in lung adenocarcinoma combined with experiments","volume":"11","author":"Li","year":"2022","unstructured":"Li W, Feng SS, Wu H, Deng J, Zhou WY, Jia MX, Shi Y, Ma L, Zeng XX, Zuberi Z, Fu D, Liu X and Chen Z. Comprehensive analysis of CDK1-associated ceRNA network revealing the key pathways LINC00460\/LINC00525-Hsa-Mir-338-FAM111\/ZWINT as prognostic biomarkers in lung adenocarcinoma combined with experiments. Cells 2022; 11: 1220.","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.athoracsur.2020.01.073","article-title":"Survival of primary stereotactic body radiation therapy compared with surgery for operable stage I\/II non-small cell lung cancer","volume":"110","author":"Khorfan","year":"2020","unstructured":"Khorfan R, Kruser TJ, Coughlin JM, Bharat A, Bilimoria KY and Odell DD. Survival of primary stereotactic body radiation therapy compared with surgery for operable stage I\/II non-small cell lung cancer. Ann Thorac Surg 2020; 110: 228-234.","journal-title":"Ann Thorac Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/ijms22041828","article-title":"Atorvastatin inhibits endothelial PAI-1-mediated monocyte migration and alleviates radiation-induced enteropathy","volume":"22","author":"Kwak","year":"2021","unstructured":"Kwak SY, Park S, Kim H, Lee SJ, Jang WS, Kim MJ, Lee S, Jang WI, Kim AR, Kim EH, Shim S and Jang H. Atorvastatin inhibits endothelial PAI-1-mediated monocyte migration and alleviates radiation-induced enteropathy. Int J Mol Sci 2021; 22: 1828.","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Lee WJ, Lee JI, Choi JW, Kong DS, Nam DH, Cho YS, Shin HJ and Seol HJ. Optimal volume of the residual tumor to predict long-term tumor control using stereotactic radiosurgery after facial nerve-preserving surgery for vestibular schwannomas. J Korean Med Sci 2021; 36: e102.","DOI":"10.3346\/jkms.2021.36.e102"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1111\/1759-7714.13621","article-title":"Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer","volume":"11","author":"Matiello","year":"2020","unstructured":"Matiello J, Dal Pra A, Zardo L, Silva R and Berton DC. Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer. Thorac Cancer 2020; 11: 3139-3144.","journal-title":"Thorac Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9777","DOI":"10.1007\/s00432-023-04875-z","article-title":"Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer","volume":"149","author":"K&#xE4","year":"2023","unstructured":"Kästle S, Stechele MR, Richter L, Schinner R, Öcal E, Alunni-Fabbroni M, De Toni E, Corradini S, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M and Kimm MA. Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer. J Cancer Res Clin Oncol 2023; 149: 9777-9786.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.3390\/ijms23105498","article-title":"Human peripheral blood mononucleocyte derived myeloid committed progenitor cells mitigate H-ARS by exosomal paracrine signal","volume":"23","author":"Chugh","year":"2022","unstructured":"Chugh RM, Bhanja P, Olea XD, Tao F, Schroeder K, Zitter R, Arora T, Pathak H, Kimler BF, Godwin AK, Perry JM and Saha S. Human peripheral blood mononucleocyte derived myeloid committed progenitor cells mitigate H-ARS by exosomal paracrine signal. Int J Mol Sci 2022; 23: 5498.","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/ph15101303","article-title":"High-altitude hypoxia influences the activities of the drug-metabolizing enzyme CYP3A1 and the pharmacokinetics of four cardiovascular system drugs","volume":"15","author":"Zhu","year":"2022","unstructured":"Zhu J, Duan Y, Duo D, Yang J, Bai X, Liu G, Wang Q, Wang X, Qu N, Zhou Y and Li X. High-altitude hypoxia influences the activities of the drug-metabolizing enzyme CYP3A1 and the pharmacokinetics of four cardiovascular system drugs. Pharmaceuticals (Basel) 2022; 15: 1303.","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"115464","DOI":"10.1016\/j.taap.2021.115464","article-title":"Safety assessment of desaminotyrosine: acute, subchronic oral toxicity, and its effects on intestinal microbiota in rats","volume":"417","author":"Li","year":"2021","unstructured":"Li F, Wang L, Cai Y, Luo Y and Shi X. Safety assessment of desaminotyrosine: acute, subchronic oral toxicity, and its effects on intestinal microbiota in rats. Toxicol Appl Pharmacol 2021; 417: 115464.","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"783197","DOI":"10.3389\/fonc.2022.783197","article-title":"The effect of inflammatory markers on the survival of advanced gastric cancer patients who underwent anti-programmed death 1 therapy","volume":"12","author":"Qu","year":"2022","unstructured":"Qu Z, Wang Q, Wang H, Jiao Y, Li M, Wei W, Lei Y, Zhao Z, Zhang T, Zhang Y and Gu K. The effect of inflammatory markers on the survival of advanced gastric cancer patients who underwent anti-programmed death 1 therapy. Front Oncol 2022; 12: 783197.","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"964115","DOI":"10.3389\/fonc.2022.964115","article-title":"Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer","volume":"12","author":"Shen","year":"2022","unstructured":"Shen F, Liu C, Zhang W, He S, Wang F, Wang J, Li Q and Zhou F. Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer. Front Oncol 2022; 12: 964115.","journal-title":"Front Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cancers11020240","article-title":"The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells","volume":"11","author":"Huong","year":"2019","unstructured":"Huong PT, Nguyen LT, Nguyen XB, Lee SK and Bach DH. The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells. Cancers (Basel) 2019; 11: 240.","journal-title":"Cancers (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"9480","DOI":"10.3390\/ijms22179480","article-title":"Ixodes ricinus salivary serpin iripin-8 inhibits the intrinsic pathway of coagulation and complement","volume":"22","author":"Kot&#xE1","year":"2021","unstructured":"Kotál J, Polderdijk SGI, Langhansová H, Ederová M, Martins LA, Beránková Z, Chlastáková A, Hajdušek O, Kotsyfakis M, Huntington JA and Chmelař J. Ixodes ricinus salivary serpin iripin-8 inhibits the intrinsic pathway of coagulation and complement. Int J Mol Sci 2021; 22: 9480.","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11060-023-04325-3","article-title":"Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery","volume":"163","author":"Kalyvas","year":"2023","unstructured":"Kalyvas A, Gutierrez-Valencia E, Lau R, Ye XY, O’Halloran PJ, Mohan N, Wong C, Millar BA, Laperriere N, Conrad T, Berlin A, Bernstein M, Zadeh G, Shultz DB and Kongkham P. Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery. J Neurooncol 2023; 163: 269-279.","journal-title":"J Neurooncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/SLA.0000000000004363","article-title":"Stereotactic body radiotherapy versus delayed surgery for early-stage non-small-cell lung cancer","volume":"272","author":"NR","year":"2020","unstructured":"Mayne NR, Lin BK, Darling AJ, Raman V, Patel DC, Liou DZ, D’Amico TA and Yang CJ. Stereotactic body radiotherapy versus delayed surgery for early-stage non-small-cell lung cancer. Ann Surg 2020; 272: 925-929.","journal-title":"Ann Surg"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00066-021-01773-6","article-title":"Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial","volume":"197","author":"Bodensohn","year":"2021","unstructured":"Bodensohn R, Kaempfel AL, Fleischmann DF, Hadi I, Hofmaier J, Garny S, Reiner M, Forbrig R, Corradini S, Thon N, Belka C and Niyazi M. Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial. Strahlenther Onkol 2021; 197: 601-613.","journal-title":"Strahlenther Onkol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"20347","DOI":"10.1038\/s41598-021-98847-3","article-title":"A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases","volume":"11","author":"Stankiewicz","year":"2021","unstructured":"Stankiewicz M, Tomasik B and Blamek S. A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases. Sci Rep 2021; 11: 20347.","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"10760296231216962","DOI":"10.1177\/10760296231216962","article-title":"Impact of stereotactic body radiotherapy on thrombin generation and platelet aggregation in patients with non-small cell lung cancer","volume":"29","author":"Bentsen","year":"2023","unstructured":"Bentsen KK, Hojbjerg JA, Vinholt PJ, Hansen O, Hvas AM and Jeppesen SS. Impact of stereotactic body radiotherapy on thrombin generation and platelet aggregation in patients with non-small cell lung cancer. Clin Appl Thromb Hemost 2023; 29: 10760296231216962.","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1245\/s10434-019-07381-0","article-title":"Population-based study on risk factors for tumor-positive resection margins in patients with gastric cancer","volume":"26","author":"van der Werf","year":"2019","unstructured":"van der Werf LR, Cords C, Arntz I, Belt EJT, Cherepanin IM, Coene PLO, van der Harst E, Heisterkamp J, Langenhoff BS, Lamme B, van Berge Henegouwen MI, Lagarde SM and Wijnhoven BPL. Population-based study on risk factors for tumor-positive resection margins in patients with gastric cancer. Ann Surg Oncol 2019; 26: 2222-2233.","journal-title":"Ann Surg Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12951-022-01325-9","article-title":"Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor","volume":"20","author":"Qu","year":"2022","unstructured":"Qu Q, Zhang Z, Guo X, Yang J, Cao C, Li C, Zhang H, Xu P, Hu Z and Tian J. Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor. J Nanobiotechnology 2022; 20: 143.","journal-title":"J Nanobiotechnology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijrobp.2020.03.005","article-title":"Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 individual treatments","volume":"107","author":"RJ","year":"2020","unstructured":"Klement RJ, Sonke JJ, Allgäuer M, Andratschke N, Appold S, Belderbos J, Belka C, Blanck O, Dieckmann K, Eich HT, Mantel F, Eble M, Hope A, Grosu AL, Nevinny-Stickel M, Semrau S, Sweeney RA, Hörner-Rieber J, Werner-Wasik M, Engenhart-Cabillic R, Ye H, Grills I and Guckenberger M. Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 individual treatments. Int J Radiat Oncol Biol Phys 2020; 107: 579-586.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/4\/ajcr0162690.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:00:18Z","timestamp":1766023218000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/4\/ajcr0162690.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/kmwi9314","relation":{},"ISSN":["2156-6976"],"issn-type":[{"type":"electronic","value":"2156-6976"}],"subject":[],"published":{"date-parts":[[2025]]}}}